Park Compounding Pharmacy Recalls Caffeine and Sodium Benzoate Vials
Park Compounding Pharmacy is recalling specific vials of Caffeine + Sodium Benzoate 500mg/mL due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score per the rubric for drug recalls with potential for temporary or medically reversible health consequences.
Plain-English summary
Chen Shwezin, Inc. dba Park Compounding Pharmacy is recalling 2 vials of Caffeine + Sodium Benzoate 500mg/mL, 35 mL vial, Rx only. The recall is due to a lack of assurance of sterility for all sterile compounded products within the expiry date.
The affected product is identified by Lot# 08062015@27 and has an expiration date of 11/4/15. The product was distributed in California (CA).
Consumers who have this specific product should contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- CAFFEINE + SODIUM BENZOATE 500MG/ML, 35 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805) 497-8258
- Manufacturer
- Chen Shwezin, Inc. dba Park Compounding Pharmacy
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 08062015@27
- Exp
- 11/4/15
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Chen Shwezin, Inc. dba Park Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Chen Shwezin, Inc. dba Park Compounding Pharmacy
See all →- SeverePark Compounding Pharmacy Recalls Methylcobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls TRI-MIX Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls Prostaglandin PGE-1 Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls TRI-MIX Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SeverePharm D Solutions Recalls Caffeine and Sodium Benzoate Injection Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereUS Compounding Recalls Zinc Sulfate Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Betamethasone Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Dexamethasone Sodium Phosphate Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Bi-Mix Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SeverePark Compounding Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18